TriSalus Life Sciences, Inc. (TLSI)
NASDAQ: TLSI · Real-Time Price · USD
3.900
-0.050 (-1.27%)
Aug 14, 2025, 4:00 PM - Market closed
TriSalus Life Sciences Market Cap
TriSalus Life Sciences has a market cap or net worth of $193.49 million as of August 15, 2025. Its market cap has increased by 14.76% in one year.
Market Cap
193.49M
Enterprise Value
200.66M
1-Year Change
14.76%
Ranking
Category
Stock Price
$3.90
Market Cap Chart
Since February 8, 2021, TriSalus Life Sciences's market cap has decreased from $328.75M to $193.49M, a decrease of -41.15%. That is a compound annual growth rate of -11.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2025 | 193.49M | 26.65% |
| Dec 31, 2024 | 152.77M | -31.30% |
| Dec 29, 2023 | 222.38M | -29.05% |
| Dec 30, 2022 | 313.44M | 1.52% |
| Dec 31, 2021 | 308.75M | -6.08% |
| Feb 8, 2021 | 328.75M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 574.57B |
| Johnson & Johnson | 416.11B |
| AbbVie | 350.86B |
| UnitedHealth Group | 236.89B |
| Novartis AG | 230.64B |
| AstraZeneca | 229.47B |
| Abbott Laboratories | 227.90B |
| Novo Nordisk | 223.00B |